SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Acquisition

1 May 2015 07:00

RNS Number : 9497L
Oxford Instruments PLC
01 May 2015
 



 

Release date: 1 May 2015

 

Oxford Instruments plc

Acquisition of Medical Imaging Resources, Inc.

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the acquisition of Medical Imaging Resources, Inc. (MIR).

 

Founded in 1990 in Ann Arbor Michigan by CEO John Vartanian, MIR specialises in the build, lease and service of mobile medical imaging labs ("mobiles").

 

The mobile labs are built in MIR's factory, with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) systems from Siemens, GE, Philips and Toshiba. These are leased to customers across the USA. MIR is also responsible for servicing its mobiles. Customers include hospitals and clinics that need additional capacity or that wish to trial MRI or CT machines without committing to the infrastructure and cost associated with a permanent unit.

 

MIR will form a part of OIHealthcare, within the Group's Service sector, which already services GE MRI and CT machines in the USA. There are a number of synergies with OIHealthcare:

 

· This will be a significant step to making OIHealthcare a multi-skilled independent service provider able to support large individual service contracts;

· Access to OIHealthcare's parts and its purchasing power for complete systems will lower MIR's operating costs;

· There will be overheads savings in those areas where duplication is eliminated;

· MIR currently sub-contracts a significant portion of the service work for its mobiles. OIHealthcare staff are located in numerous states and once trained will take over the work and will be able to bring the margin in-house.

 

Consideration, which will be satisfied from existing facilities, comprises $10.4 million (c. £6.8 million) on completion followed by a further $10.1 million (c. £6.6 million) earn-out payable one year later. MIR has approximately $3.0 million (c. £2.0 million) net debt at completion.

 

In the year to 31 December 2014, MIR had sales of $16.6 million (c. £10.8 million), profit before tax of $2.8 million (c. £1.8 million) and EBITDA of $5.6 million (c. £3.6 million). At 31 December 2014, MIR had gross assets of $9.4 million (c. £6.1 million).

 

 

 

Jonathan Flint (Chief Executive) and Kevin Boyd (Finance Director) will host a conference call for analysts and investors on this announcement at 9:30 am (UK time), today 1 May. To join the call, please use the dial-in numbers below:

 

Dial: +44 (0)20 3139 4830

PIN: 89662683#

 

 

 

- Ends -

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Jack Holden

 

Issued for and on behalf of Oxford Instruments plc

 

 

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.

The first technology business to be spun out from Oxford University, Oxford Instruments objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments; Nuclear Magnetic Resonance; x-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAFLEDSDSEAF
Date   Source Headline
8th Jan 20147:00 amRNSExtension Of Offer And Offer Update
6th Jan 20142:35 pmPRNTotal Voting Rights
2nd Jan 20149:47 amPRNDirector/PDMR Shareholding
2nd Jan 20149:26 amPRNHolding(s) in Company
19th Dec 20137:00 amRNSIrrevocable undertakings
17th Dec 201312:57 pmRNSOffer Document for Andor Technology plc
16th Dec 201311:34 amPRNHolding(s) in Company
11th Dec 201310:14 amPRNDirector/PDMR Shareholding
10th Dec 20134:29 pmRNSOffer for Andor Technology plc
9th Dec 20137:00 amRNSStatement re: possible offer by Oxford Instruments
6th Dec 20136:28 pmRNSIncreased proposed offer for Andor Technology plc
5th Dec 20139:36 amPRNAdditional Listing
2nd Dec 20132:37 pmPRNDirector/PDMR Shareholding
2nd Dec 20131:52 pmPRNTotal Voting Rights
2nd Dec 20137:01 amRNSResponse to possible offer from Oxford Instruments
27th Nov 20135:47 pmRNSRe: announcement by Oxford Instruments plc
27th Nov 20132:37 pmRNSUpdate on Possible Offer for Andor Technology plc
20th Nov 20139:45 amPRNForm 8 (OPD) Andor Technology plc
19th Nov 20134:26 pmPRNHolding(s) in Company
18th Nov 201312:00 pmRNSForm 8.3 - [Andor Technology Limited]
13th Nov 20132:36 pmRNSForm 8.3 - [Andor Technology Limited]
12th Nov 20133:06 pmRNSResponse to statement made by Andor Technology plc
12th Nov 20138:23 amRNSResponse to possible offer from Oxford Instruments
12th Nov 20137:01 amRNSStatement re Possible Offer
12th Nov 20137:01 amRNSHalf Yearly Report
4th Nov 20139:17 amPRNTotal Voting Rights
30th Oct 20131:53 pmPRNDirector/PDMR Shareholding
21st Oct 20138:36 amPRNHolding(s) in Company
14th Oct 20134:35 pmRNSNotice of Results
9th Oct 201311:00 amPRNAdditional Listing
1st Oct 20133:18 pmPRNDirector/PDMR Shareholding
1st Oct 20131:11 pmPRNTotal Voting Rights
1st Oct 20138:37 amPRNHolding(s) in Company
30th Sep 201311:37 amPRNHolding(s) in Company
25th Sep 20136:08 pmPRNHolding(s) in Company
25th Sep 20138:21 amPRNHolding(s) in Company
16th Sep 20138:49 amPRNHolding(s) in Company
13th Sep 20138:30 amPRNHolding(s) in Company
11th Sep 201312:33 pmPRNAdditional Listing
11th Sep 201311:07 amPRNResult of AGM
11th Sep 201310:47 amPRNDirectorate Change
10th Sep 20137:00 amRNSAGM Statement
2nd Sep 20132:58 pmPRNTotal Voting Rights
2nd Sep 20139:42 amPRNDirector/PDMR Shareholding
19th Aug 20133:32 pmPRNHolding(s) in Company
5th Aug 20131:33 pmPRNTotal Voting Rights
30th Jul 20131:48 pmPRNDirector/PDMR Shareholding
23rd Jul 20131:48 pmPRNHolding(s) in Company
12th Jul 20137:00 amRNSInterim Management Statement
10th Jul 20133:07 pmRNSNotice of IMS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.